Literature DB >> 21629285

US academic drug discovery.

Stephen Frye, Marina Crosby, Teresa Edwards, Rudolph Juliano.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21629285      PMCID: PMC4461005          DOI: 10.1038/nrd3462

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  13 in total

Review 1.  The druggable genome.

Authors:  Andrew L Hopkins; Colin R Groom
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

Review 2.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

3.  Small molecules: the missing link in the central dogma.

Authors:  Stuart L Schreiber
Journal:  Nat Chem Biol       Date:  2005-07       Impact factor: 15.040

4.  Drug discovery in jeopardy.

Authors:  Pedro Cuatrecasas
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

5.  Open access chemical and clinical probes to support drug discovery.

Authors:  Aled M Edwards; Chas Bountra; David J Kerr; Timothy M Willson
Journal:  Nat Chem Biol       Date:  2009-07       Impact factor: 15.040

Review 6.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

7.  The emerging academic drug-discovery sector.

Authors:  Paul G Wyatt
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

8.  The role of public-sector research in the discovery of drugs and vaccines.

Authors:  Ashley J Stevens; Jonathan J Jensen; Katrine Wyller; Patrick C Kilgore; Sabarni Chatterjee; Mark L Rohrbaugh
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

9.  Academia-industry partnerships in drug discovery.

Authors:  Michael Dalrymple; Debbie Taylor; Catherine Kettleborough; Justin Bryans; Roberto Solari
Journal:  Expert Opin Drug Discov       Date:  2006-06       Impact factor: 6.098

Review 10.  Integration of small-molecule discovery in academic biomedical research.

Authors:  Michael Ohlmeyer; Ming-Ming Zhou
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug
View more
  27 in total

1.  Computer-aided molecular design under the SWOTlight.

Authors:  Darren V S Green; Andrew R Leach; Martha S Head
Journal:  J Comput Aided Mol Des       Date:  2011-12-15       Impact factor: 3.686

2.  Academic-Industrial Collaboration: Toward the Consilience of Two Solitudes.

Authors:  Stephen Hanessian
Journal:  ACS Med Chem Lett       Date:  2015-12-22       Impact factor: 4.345

3.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

4.  UK academic drug discovery.

Authors:  Cathy Tralau-Stewart; Caroline M R Low; Nicola Marlin
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

5.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

6.  Academic Drug Development: The DRIVE Model.

Authors:  Dennis Liotta; George Painter
Journal:  ACS Med Chem Lett       Date:  2018-04-02       Impact factor: 4.345

7.  Drug discovery in an academic setting: playing to the strengths.

Authors:  Donna M Huryn
Journal:  ACS Med Chem Lett       Date:  2013-01-17       Impact factor: 4.345

8.  Drug discovery 2012 and beyond.

Authors:  David P Rotella
Journal:  ACS Med Chem Lett       Date:  2012-01-31       Impact factor: 4.345

Review 9.  Mitigating risk in academic preclinical drug discovery.

Authors:  Jayme L Dahlin; James Inglese; Michael A Walters
Journal:  Nat Rev Drug Discov       Date:  2015-04       Impact factor: 84.694

Review 10.  Contributions of academic laboratories to the discovery and development of chemical biology tools.

Authors:  Donna M Huryn; Lynn O Resnick; Peter Wipf
Journal:  J Med Chem       Date:  2013-05-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.